Study Stopped
Difficulty with recruitment
PlayGait: A Dynamic Exoskeleton
1 other identifier
interventional
1
1 country
1
Brief Summary
PlayGait is an investigational dynamic energy storage and return (ESR) lower-limb exoskeleton for young children with cerebral palsy (CP), that stores energy while the child is in the stance phase of walking and returns that energy in terminal stance and early swing phase of walking. PlayGait assists with the passive dynamics of walking through an exotendon (comprised of a spring in series with a cable). The overall objective of this investigational device is to promote correct walking patterns that encourage proper bone alignment, muscle recruitment, and strengthening during walking practice in young children with CP. The study will evaluate children with CP's activity levels in the community with and without PlayGait. The study will consist of three lab visits and two, 7-day periods at home.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 11, 2022
CompletedFirst Submitted
Initial submission to the registry
March 24, 2022
CompletedFirst Posted
Study publicly available on registry
April 8, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 3, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 3, 2023
CompletedOctober 10, 2023
October 1, 2023
10 months
March 24, 2022
October 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cadence
Low, medium, and high activity rate
7 days with baseline condition; 7 days with PlayGait condition
Shifts in cadence
Shifts from low to medium cadence and shifts from medium to high cadence
7 days with baseline condition; 7 days with PlayGait condition
Secondary Outcomes (5)
1 minute walk test
1st lab session (baseline); 3rd lab session with PlayGait after 7 days of wearing PlayGait
10 meter walk test
1st lab session (baseline); 3rd lab session with PlayGait after 7 days of wearing PlayGait
Pediatric Balance Scale
1st lab session (baseline); 3rd lab session with PlayGait after 7 days of wearing PlayGait
Average steps per day
Baseline Condition: 7 days in the community without PlayGait (no lower-limb assistive devices); PlayGait condition: 7 days with PlayGait
Time of PlayGait use
PlayGait condition: 7 days in the community with PlayGait
Study Arms (2)
PlayGait (Exoskeleton)
EXPERIMENTALExperimental lower-limb device.
Baseline
ACTIVE COMPARATORBaseline condition without using any prescribed lower-limb orthoses.
Interventions
Eligibility Criteria
You may qualify if:
- Age 3 - 4 years (at time of informed consent)
- Hemiplegic cerebral palsy
- If child uses an ankle-foot orthosis (AFO), parent/caregiver is willing to have the child stop wearing their prescribed AFO during data collections (lab sessions and two 7-day periods at home)
- Ability to walk at least 10 meters without the use of assistive devices or AFOs
- Ability to walk at least 1 minute without the use of assistive devices or AFOs
- Stiff knee gait - less than normal knee flexion during swing phase
- Hip flexion passive range of motion contracture less than 20 degrees
- Gross Motor Function Classification System (GMFCS) Levels I-II
- Modified Ashworth Scale (MAS) \<=2 for the gastrocnemius soleus, rectus femoris, and hamstrings
- Family has resources to attend all study sessions (transportation, schedule)
- Ability to speak and understand in English
You may not qualify if:
- Orthopedic surgery in the last year
- Foster children or wards of the state
- Use wheelchair or stroller mobility as their primary method of independent mobility
- Severe visual impairment such that the visual impairment itself functionally limits mobility
- Phenol or Botox injections to the legs in the last 3 months
- Uncontrolled seizure disorder, defined as any seizure in the last 3 months that influenced mobility skills and function (seizures which did not affect mobility are acceptable)
- Lower limb fracture in the last 3 months
- Planned surgery or changes to movement disorder medication during the study period
- Inability to understand directions sufficiently to complete the study assessments
- Cognitive, behavioral, or any other issues that may not allow for effective study participation
- Unwilling to complete the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Orthocare Innovations, LLC
Edmonds, Washington, 98020, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jessica Zistatsis, MSME
Orthocare Innovations
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 24, 2022
First Posted
April 8, 2022
Study Start
March 11, 2022
Primary Completion
January 3, 2023
Study Completion
January 3, 2023
Last Updated
October 10, 2023
Record last verified: 2023-10